FAQ’s
No. This is not a diagnostic test and does not confirm or rule out any medical condition. It is for screening and awareness.
Early insight refers to understanding general biological patterns that may change over time. It supports awareness, not diagnosis.
Kits are collected or distributed through authorised healthcare partners, clinics, or approved outreach teams. Sample return follows a supervised and structured process.
These signals reflect variations in biological patterns over time and should be interpreted within clinical context, not as medical findings.
We analyse biological markers from your sample to observe general molecular and physiological patterns. This supports structured screening, not diagnosis.
No, we do not offer a free version or trial. The screening service is delivered through authorised healthcare partners as part of a clinically supervised process. This ensures that sample collection, analysis, and interpretation are handled within appropriate healthcare pathways.
Payment methods or subscription-based vary depending on the authorised healthcare partner or clinic through which the screening is accessed. Accepted options typically include standard digital payments and card transactions processed within the partner healthcare system.
This depends on individual or clinician guidance. The system supports flexible screening rather than fixed intervals.
Licensed clinicians provide oversight, ensuring responsible interpretation within real-world healthcare settings and ethical and regulatory boundaries.
Accredited laboratories perform validated analysis using standardised methods, including molecular and genomic techniques such as NGS.
This system focuses on early biological patterns and structured screening workflows rather than reactive symptom-led testing. Unlike routine testing, which is primarily reactive and symptom-driven, this approach is designed for proactive, innovation-led screening that integrates clinical oversight, advanced laboratory analysis, and Real-World Evidence (RWE) generation to enable earlier and more structured health insight at a population level.
You can request a test through authorised healthcare partners or participating clinics. Once requested, a screening kit is provided and sample collection is guided through clinical pathways.
This depends on individual or clinician guidance. The system supports flexible screening rather than fixed intervals.
Anonymised screening data contributes to a structured RWE framework, supporting population-level health insights over time.
Licensed clinicians provide oversight, ensuring responsible interpretation within real-world healthcare settings and ethical and regulatory boundaries.
Yes. The process is non-invasive comfortable and designed for simple home collection using swab or stool kits, under clinical guidance where required.
Accredited laboratories perform validated analysis using standardised methods, including molecular and genomic techniques such as NGS.
